INHIBITORY PROPERTIES OF NIP-121, A POTASSIUM CHANNEL OPENER, ON HIGH POTASSIUM-INDUCED AND NOREPINEPHRINE-INDUCED CONTRACTION AND CALCIUM MOBILIZATION IN RAT AORTA

被引:0
作者
YAMASHITA, T [1 ]
MASUDA, Y [1 ]
TANAKA, S [1 ]
机构
[1] NISSAN CHEM IND CO LTD, SHIRAOKA RES STN BIOL SCI, MINAMI SAITAMA, SAITAMA 34902, JAPAN
关键词
POTASSIUM CHANNEL OPENER; NIP-121; CROMAKALIM; VASORELAXATION; INTRACELLULAR CA2+; RAT AORTA;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the effects of NIP-121, a potas slum channel opener, on KC1- and norepinephrine (NE)induced contraction, the phasic-contraction under the Ca2+-free condition and cytosolic free-Ca2+ mobilization using isolated rat aorta. NIP-121 as well as cromakalim inhibited, in the KC1- and NE-contractions concentration dependently. Glibenclamide, an ATP-sensitive potassium channel blocker, competitively reversed their inhibition. On the other hand, they did not inhibit the phasic-contractions induced by NE in Ca2+-free medium. In Fura-2-loaded rat aorta, NIP-121 inhibited only the late phase of the NE-induced cytosolic Ca2+ level ([Ca2+](cyt)) increases that were inhibited by nicardipine. However, it did not inhibit the first [Ca2+](cyt) increase, which was completely abolished by repeated applications of NE in Ca2+-free medium. Neither did it inhibit phorbol ester-induced contraction. The vasorelaxant mechanism of NIP-121 is attributable to the decrease in Ca2+ influx passing through the membrane Ca2+ permeable systems. In addition, inhibition of Ca2+ release from sarcoplasmic reticulum (SR) and of protein kinase C (PKC) activation may not be involved in vasorelaxation induced by NIP-121.
引用
收藏
页码:890 / 895
页数:6
相关论文
共 26 条
[1]  
BRAY K M, 1988, Pfluegers Archiv European Journal of Physiology, V411, pR202
[2]  
CHIU PJS, 1987, HYPERTENSION, V10, P360
[4]  
COWLRICK IS, 1988, BRIT J PHARMACOL, V95, pP640
[5]   COMPARISON OF THE EFFECTS OF BRL-34915 AND VERAPAMIL ON ELECTRICAL AND MECHANICAL-ACTIVITY IN RAT PORTAL-VEIN [J].
HAMILTON, TC ;
WEIR, SW ;
WESTON, AH .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (01) :103-111
[6]   CROMAKALIM, NICORANDIL AND PINACIDIL - NOVEL DRUGS WHICH OPEN POTASSIUM CHANNELS IN SMOOTH-MUSCLE [J].
HAMILTON, TC ;
WESTON, AH .
GENERAL PHARMACOLOGY, 1989, 20 (01) :1-9
[7]   ISOQUINOLINESULFONAMIDES, NOVEL AND POTENT INHIBITORS OF CYCLIC-NUCLEOTIDE DEPENDENT PROTEIN-KINASE AND PROTEIN KINASE-C [J].
HIDAKA, H ;
INAGAKI, M ;
KAWAMOTO, S ;
SASAKI, Y .
BIOCHEMISTRY, 1984, 23 (21) :5036-5041
[8]   CHARACTERISTICS OF KRN2391, A NOVEL VASODILATOR, COMPARED WITH THOSE OF CROMAKALIM, PINACIDIL AND NIFEDIPINE IN RAT AORTA [J].
KASHIWABARA, T ;
NAKAJIMA, S ;
IZAWA, T ;
FUKUSHIMA, H ;
NISHIKORI, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 196 (01) :1-7
[9]  
MASUDA Y, 1991, EUR J PHARMACOL, V195, P323
[10]   THE ANTIHYPERTENSIVE PROPERTY OF NIP-121, A NOVEL POTASSIUM CHANNEL OPENER IN RATS [J].
MASUDA, Y ;
ARAKAWA, C ;
YOKOYAMA, T ;
SHIGENOBU, K ;
TANAKA, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (02) :190-197